Replies to post #78376 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Agreed... that's why the science progression is my primary concern along with being kept up to date.

http://clinicaltrials.gov/ct2/results?term=cellceutix

http://cellceutix.com/category/press-release/#sthash.sOGrM5ZC.dpbs





In Reply to 'sox040713'
I think an impressive bottom-line data will push the SP to the $4-$5 range, but only short term catalyst is the partnership/license deal that can significantly increase the SP. Only Leo knows whether a deal is in the works. Uplisting may increase the SP temporarily, but the gain will not last if the science does not progress.

[edge]

Let's keep our options open, anything can happen. What if DF came out (not Leo) and published stellar Kevetrin trial data to date? Would the market believe Cellceutix then or is this old ho hum news? Who knows.................................where's Pfizer?